Meth Withdrawal Timeline: What Happens, When, and the Risk Nobody Mentions

Meth withdrawal is not physically dangerous in the way alcohol or benzodiazepine withdrawal is — it does not typically cause seizures or kill people directly. That fact gets repeated so often that it obscures the real risk, which is psychiatric: the depression of early withdrawal is severe, and it carries a genuine risk of suicide.

The timeline

The crash — first 24 to 72 hours

Begins within about 24 hours of the last dose and hits hardest across the first three days. Overwhelming exhaustion, very long sleep, large appetite increase, flat or heavy mood, and strong cravings. Some people sleep almost continuously; others cannot sleep despite exhaustion.

Acute withdrawal — days 3 to 10

The hardest stretch psychiatrically. Depression, anhedonia (nothing feels good or interesting), irritability, agitation, anxiety, vivid unpleasant dreams, and intense cravings. Any residual psychosis usually settles during the first week. This is the window where suicide risk is highest and where supervision matters most.

Improvement — around day 10 to 14

Acute symptoms improve substantially by roughly the two-week mark. Sleep and appetite start to regulate. This is real improvement, and it is worth telling people it is coming, because in week one it does not feel like it will.

Post-acute — 2 to 6 months, sometimes longer

A longer tail of low mood, low motivation, cognitive fog, and episodic cravings that arrive in waves rather than constantly. This phase is where most relapse happens, precisely because the acute crisis is over and support often falls away.

This tail is not weakness or a failed recovery — it tracks the underlying neurobiology. Dopamine systems recover over months to years, not weeks, and cognitive function lags behind even that.

What helps

• Supervision in the first two weeks — ideally daily contact, because of the suicide risk
• Sleep, food and hydration — unglamorous, and the biggest short-term lever
• Treating co-occurring depression — distinguishing withdrawal depression from an underlying disorder needs a clinician, and it matters
• Structure — unfilled time during the anhedonia phase is the highest-risk state there is
• Contingency management — the most evidence-supported treatment for stimulant use disorder, and it works partly because it supplies external reward while the internal reward system is offline

There are no approved medications

No medication is FDA-approved to treat methamphetamine withdrawal or stimulant use disorder. Clinicians may treat individual symptoms — sleep, agitation, depression — and some combinations are under study, but anyone offering a “meth detox medication” as an established treatment is overstating the evidence. Behavioural treatment is the evidence base here.

Is medical detox necessary?

Not always in the way it is for alcohol, but supervised settings consistently produce better outcomes than going it alone — mainly because they cover the psychiatric risk window and the first cravings. Supervision matters most where there is a history of psychosis or self-harm, concurrent alcohol, benzodiazepine or opioid use (which can be medically dangerous to stop), serious medical conditions, or no safe and stable place to stay.